The Drug Enforcement Administration, or DEA, has told House lawmakers that the agency is “now conducting its review” of marijuana as a Schedule 1 drug, according to Punchbowl News, citing a letter obtained by the news service. Publicly traded companies in the cannabis space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACB:
- Rising High: Exclusive talk with REIT Healing Realty Trust
- Rising High: Exclusive talk with biotech company Tryp Therapeutics
- Rising High: Exclusive talk with cannabis REIT NewLake Capital
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Republican Rep. to introduce cannabis legalization bill, Forbes says
